In today's installment of Good Buy or Goodbye, host Julie Hyman welcomes on Washington Crossing Advisors senior portfolio manager Chad Morganlander to discuss the best investing strategies within the
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces it has reached its three-year, $90 million grant commitment to improve accessibilit
The SPDR S&P 500 ETF Trust posted a 1.21% gain in July, underperforming Vanguard's Dividend Appreciation Index Fund ETF Shares by +3.97%. The top 15 dividend growth stocks for August 2024 offer an ave
INDIANAPOLIS--(BUSINESS WIRE)--Irvington Prep Academy in Indianapolis unveiled first ever weight room, fitness space, provided by Elevance Health and Impact Fitness Foundation.
Elevance Health's health insurance segment is well diversified, with a meaningful exposure to commercial services-only memberships and Medicaid. ELV has been doing a great job handling the current env
Wednesday, Elevance Health Inc.  ELV reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.

Elevance Health: Buy A Dividend Growth Machine

09:15am, Thursday, 18'th Jul 2024
Elevance Health, Inc. has shown remarkable dividend growth in the past decade, exceeding revenue and EPS expectations for the first quarter. Elevance's balance sheet remains A-rated, and shares of the
Elevance Health's (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense level. Adjusted earnings are reiterated to be at a minimum of $37.20 per
Elevance Health, Inc. (NYSE:ELV ) Q2 2024 Earnings Call Transcript July 17, 2024 8:30 AM ET Company Participants Steve Tanal - VP of IR Gail Boudreaux - President and CEO Mark Kaye - CFO Felicia Norwo
Elevance Health (ELV) topped analyst expectations with its second-quarter results, but shares of the health insurance provider fell in intraday trading Wednesday amid declining Medicaid membership.
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street es
Elevance Health Inc.  ELV reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.
Elevance Health (ELV) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.99 per share. This compares to earnings of $9.04 per share a year ago.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE